UCB reported EUR2.18B in Loan Capital for its fiscal semester ending in December of 2025.





Loan Capital Change Date
Alcon AG USD 4.69B 41M Sep/2026
Almirall EUR 303.77M 21.04M Jun/2026
argenx SE USD 36M 432K Jun/2026
AstraZeneca USD 28.8B 2.79B Sep/2026
Bayer EUR 37.7B 6.54B Sep/2026
Genmab DKK 4.96B 28M Jun/2026
GlaxoSmithKline GBP 21.7B 7.75B Sep/2026
GRIFOLS EUR 8.69B 1.52B Sep/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lakefront Biotherapeutics EUR 1.83M 2.94M Sep/2026
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.34B 866M Sep/2026
Novartis USD 38.38B 893M Sep/2026
Orion EUR 103.4M 7.2M Jun/2026
Recordati EUR 1.57B 123.2M Sep/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 16.28B 1.63B Sep/2026
UCB EUR 2.18B 634M Dec/2025
Unibail Rodamco EUR 21.57B 88M Dec/2025